← FDA DRUG APPROVALS

FDA NDA · NDA020927

AREDIA

Sponsor: NOVARTIS

APPLICATION
NDA020927
TYPE
NDA
ORIGINAL APPROVAL
1998-09-22
LATEST ACTION
1998-09-22
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

AREDIAPrescription
PAMIDRONATE DISODIUM 60MG/VIAL · INJECTABLE · INJECTION
AREDIAPrescription
PAMIDRONATE DISODIUM 90MG/VIAL · INJECTABLE · INJECTION
AREDIAPrescription
PAMIDRONATE DISODIUM 30MG/VIAL · INJECTABLE · INJECTION

Approval history

1998-09-22Type 6 - New Indication (no longer used) · Original · standard — Review ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →